Skip to content

Author

Othman Alomeir

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Emergency Department Utilization Among Cancer Patients Receiving Immune Checkpoint Inhibitors: Patterns, Clinical Characteristics, and Associated Factors

Background: Immune checkpoint inhibitors (ICIs) have become an integral component of cancer treatment across multiple solid and hematologic malignancies. Although these agents can produce durable clinical responses, they are also associated with immune-related adverse events that may lead to emergency department (ED) v...

Raghad Alhotirshi, Sadeem Allqmani, Bushra F. Alqurashi et al. · 0 citations
Open access Oct 2026

Bleomycin-Associated Pulmonary Toxicity in Adult Cancer Patients: Clinical Characteristics and Outcomes from a Single-Center Retrospective Cohort

Bleomycin-associated pulmonary toxicity was documented in nearly one-quarter of adult patients with cancer receiving bleomycin, whereas pulmonary fibrosis was uncommon, highlighting the clinical impact of bleomycin-associated pulmonary toxicity.

Lujain Samarin, Attiah Khobrani, Bayader Al-Sobhi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.